Nuformix plc Banner Image

Nuformix plc

  • Ticker NFX
    Exchange LSE More
  • Industry Biotechnology More
  • Sector Healthcare More
Nuformix plc Logo Image
  • 1-10 Employees
  • Based in London, England
Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. Its lead programs include NXP001, which is in Phase 1-ready stage for oncology supportive care; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis. The company is also developing NXP004, which is in theMore research Phase for treating oncology. It also has an option agreement with Oxilio Ltd. for developing and exploiting NXP001 for the treatment of cancer. Nuformix plc was founded in 2008 and is based in London, the United Kingdom.
4.8 / 5.0 (75)

Nuformix plc reports have an aggregate usefulness score of 4.8 based on 75 reviews.

Nuformix plc

Most Recent Annual Report

Nuformix plc
MOST RECENT 2022 Annual Report

Older/Archived Annual Reports

Nuformix plc Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!